Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of NRBO will decline by -31.16% over the next 2 Weeks and hit $1.62 by Monday, January 6, 2025. In that time frame, NRBO's share price is expected to range between $1.42 and $1.82.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jan 6, 2025 | 1.43 | 1.62 | 1.83 |
| Jan 3, 2025 | 1.45 | 1.66 | 1.85 |
| Jan 2, 2025 | 1.49 | 1.67 | 1.87 |
| Jan 1, 2025 | 1.57 | 1.77 | 1.96 |
| Dec 31, 2024 | 1.62 | 1.81 | 2.00 |
| Dec 30, 2024 | 1.57 | 1.77 | 1.98 |
| Dec 27, 2024 | 1.59 | 1.80 | 2.01 |
| Dec 26, 2024 | 1.62 | 1.82 | 2.02 |
| Dec 25, 2024 | 1.71 | 1.91 | 2.12 |
| Dec 24, 2024 | 1.76 | 1.95 | 2.15 |
NRBO shares remained flat - in Wednesday, November 27, 2024's trading session, starting and closing at a previous close of - to move at $2.36. The stock demonstrated notable intraday movement (see NRBO's key stats for a full breakdown), fluctuating between $2.36 and $2.36, a 0 trading range. While recent weeks have seen some volatility, NRBO has managed to secure a +4.42% gain over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 96.8K shares changing hands, 53.78K fewer than the previous session. This amounted to $228.44K in total market activity.
Will NRBO Continue Its Downward Trend?
According to analyst ratings and projections for NRBO, NeuroBo Pharmaceuticals, Inc. shares are anticipated to decrease by -29.00%, potentially reaching $1.83 per share by January 6, 2025. Short-term technical indicators for NRBO currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the NRBO stock forecast, now is not the best time to buy NRBO stock because its current trading price is +45.27% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on NRBO covering social and institutional perspectives.
NRBO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into NRBO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 20.77% to 29.96%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 37.91%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 42.53%, maintains a neutral outlook for the long term. Insights into NRBO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
NeuroBo Pharmaceuticals, Inc. Monthly Forecast 2024–2025
December 2024
According to our latest forecast models, NeuroBo Pharmaceuticals, Inc. (NRBO) is positioned to show a strong performance in December 2024. The price is predicted to move between $0.00 and $23.64, settling at an average of $0.00. This could translate to a -100.00% loss.
January 2025
Based on current market signals, NeuroBo Pharmaceuticals, Inc. is projected to trend january 2025. We forecast a trading range from $0.00 to $24.19, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
February 2025
Our predictive algorithms indicate NeuroBo Pharmaceuticals, Inc. stock may see a shift in February 2025. The expected range spans $0.00–$24.26, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
March 2025
Analyzing established trends, NeuroBo Pharmaceuticals, Inc. looks set to move in March 2025. Projections place the stock between $0.00 and $26.23, averaging around $0.00. This suggests a -100.00% loss from current levels.
April 2025
Market indicators suggest NeuroBo Pharmaceuticals, Inc. could experience notable changes during April 2025. Prices could fluctuate within $0.00 to $25.38, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
May 2025
Forecasting for May 2025, models estimate that NeuroBo Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $23.04, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
June 2025
According to our latest forecast models, NeuroBo Pharmaceuticals, Inc. (NRBO) is positioned to show a strong performance in June 2025. The price is predicted to move between $0.00 and $24.57, settling at an average of $0.00. This could translate to a -100.00% loss.
July 2025
Based on current market signals, NeuroBo Pharmaceuticals, Inc. is projected to trend july 2025. We forecast a trading range from $0.00 to $24.89, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
August 2025
Our predictive algorithms indicate NeuroBo Pharmaceuticals, Inc. stock may see a shift in August 2025. The expected range spans $0.00–$23.04, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
September 2025
Analyzing established trends, NeuroBo Pharmaceuticals, Inc. looks set to move in September 2025. Projections place the stock between $0.00 and $25.08, averaging around $0.00. This suggests a -100.00% loss from current levels.
October 2025
Market indicators suggest NeuroBo Pharmaceuticals, Inc. could experience notable changes during October 2025. Prices could fluctuate within $0.00 to $23.07, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
November 2025
Forecasting for November 2025, models estimate that NeuroBo Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $24.38, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
NRBO's history of dividends and stock splits also plays a role in long-term investor confidence.